Harifi Mohammad Mostafa, Ghadirian Hesam, Karimi-Yarandi Koroush, Nouri Mohsen, Ahmadiabhari Seyedsina, Mortazavi Abolghasem
Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Department of Neurosurgery, Jamaica Hospital Medical Center Queen, New York, NY, USA.
Korean J Neurotrauma. 2024 Nov 22;20(4):262-275. doi: 10.13004/kjnt.2024.20.e37. eCollection 2024 Dec.
This randomized controlled trial (RCT) aimed to compare the short-, mid-, and long-term outcomes in patients with malignant intracranial hypertension undergoing either decompressive craniectomy (DC) or hinge craniotomy (HC).
In this prospective RCT, 38 patients diagnosed with malignant intracranial hypertension due to ischemic infarction, traumatic brain injury, or non-lesional spontaneous intracerebral hemorrhage, who required cranial decompression, were randomly allocated to the DC and HC groups.
The need for reoperation, particularly cranioplasty, in the DC group was significantly different from that in the HC group. The percentage of brain expansion was higher in the DC group versus the HC group; however, the difference was not significant. There was no significant intergroup difference in the functional outcome according to the modified Rankin Scale or the Glasgow Outcome Scale. Additionally, no significant intergroup differences were observed in the rates of in-hospital complications.
The HC and DC groups did not significantly differ in the rate of hospital complications such as infection, need for reoperation owing to the lack of intracranial pressure control, wound healing problems, or bone infection. Our results suggest that by performing HC, the probability of the need for major surgery (cranioplasty) is reduced, thereby removing financial burden from the patient and the health system.
Iranian Registry of Clinical Trials Identifier: IRCT20180515039678N1.
本随机对照试验(RCT)旨在比较接受减压性颅骨切除术(DC)或铰链式颅骨切开术(HC)的恶性颅内高压患者的短期、中期和长期结局。
在这项前瞻性RCT中,38例因缺血性梗死、创伤性脑损伤或非病变性自发性脑出血而诊断为恶性颅内高压且需要颅骨减压的患者被随机分配至DC组和HC组。
DC组再次手术的需求,尤其是颅骨修补术,与HC组有显著差异。DC组脑膨出的百分比高于HC组;然而,差异不显著。根据改良Rankin量表或格拉斯哥结局量表评估,两组在功能结局方面无显著组间差异。此外,两组在院内并发症发生率方面未观察到显著差异。
HC组和DC组在医院并发症发生率方面无显著差异,如感染、因颅内压控制不佳而需要再次手术、伤口愈合问题或骨感染。我们的结果表明,通过实施HC,可降低进行大手术(颅骨修补术)的可能性,从而减轻患者和卫生系统的经济负担。
伊朗临床试验注册中心标识符:IRCT20180515039678N1。